P. Veldhuis

965 total citations
9 papers, 394 citations indexed

About

P. Veldhuis is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, P. Veldhuis has authored 9 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Genetics. Recurrent topics in P. Veldhuis's work include RNA modifications and cancer (3 papers), Genetics and Neurodevelopmental Disorders (2 papers) and Esophageal and GI Pathology (2 papers). P. Veldhuis is often cited by papers focused on RNA modifications and cancer (3 papers), Genetics and Neurodevelopmental Disorders (2 papers) and Esophageal and GI Pathology (2 papers). P. Veldhuis collaborates with scholars based in Netherlands, United States and Germany. P. Veldhuis's co-authors include Klaas Kok, Anke van den Berg, Susan L. Naylor, Charles H.C.M. Buys, Miriam Hulsbeek, Charles H. Hensel, Dawn Garcia, RuiHua Xiang, Maria C. Daly and Debora de Jong and has published in prestigious journals such as European Journal of Cancer, Genomics and Lung Cancer.

In The Last Decade

P. Veldhuis

9 papers receiving 382 citations

Peers

Countries citing papers authored by P. Veldhuis

Since Specialization

Citations

This map shows the geographic impact of P. Veldhuis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Veldhuis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Veldhuis more than expected).

Fields of papers citing papers by P. Veldhuis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Veldhuis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Veldhuis. The network helps show where P. Veldhuis may publish in the future.

Co-authorship network of co-authors of P. Veldhuis

This figure shows the co-authorship network connecting the top 25 collaborators of P. Veldhuis. A scholar is included among the top collaborators of P. Veldhuis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Veldhuis. P. Veldhuis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Managed Clinical Network for esophageal cancer enables reduction of variation between hospitals trends in treatment strategies, lead time, and 2-year survival 2022 ·European Journal of Surgical Oncology ·(unknown), Rob H.A. Verhoeven, Wouter B. Nagengast, Vera Oppedijk, (unknown), Johan M. van Rooijen, P. Veldhuis, Sabine Siesling, Ewout A. Kouwenhoven	3
2	Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study 2018 ·European Journal of Cancer ·Leonie R. van der Werf, Johan L. Dikken, Esmee M. van der Willik, Mark I. van Berge Henegouwen, Grard A. P. Nieuwenhuijzen, Bas P. L. Wijnhoven, Koop Bosscha, Nicole C.T. van Grieken, (unknown), Richard van Hillegersberg, V.E.P.P. Lemmens, John Theodorus Plukker, Camiel Rosman, J.W. van Sandick, Peter D. Siersema, Geert W. M. Tetteroo, P. Veldhuis, Francine E.M. Voncken	37
3	An Evolutionary Rearrangement of the Xp11.3–11.23 Region in 3p21.3, a Region Frequently Deleted in a Variety of Cancers 1999 ·Genomics ·Tineke Timmer, P. Terpstra, Anke van den Berg, P. Veldhuis, Arja ter Elst, Anneke Y. van der Veen, Klaas Kok, Susan L. Naylor, Charles H.C.M. Buys	15
4	NormalFHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region 1997 ·Genes Chromosomes and Cancer ·Anke van den Berg, (unknown), Klaas Kok, Tineke Timmer, Anneke Y. van der Veen, P. Veldhuis, Lou de Leij, (unknown), Susan L. Naylor, Jeremy C. Smith, (unknown)	42
5	Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis 1996 ·Genes Chromosomes and Cancer ·Anke van den Berg, Miriam Hulsbeek, Debora de Jong, Klaas Kok, P. Veldhuis, Joëlle Roche, C.H.C.M. Buys	56
6	Isolation of the Human Semaphorin III/F Gene (SEMA3F) at Chromosome 3p21, a Region Deleted in Lung Cancer 1996 ·Genomics ·RuiHua Xiang, Charles H. Hensel, Dawn Garcia, (unknown), Klaas Kok, Maria C. Daly, (unknown), Anke van den Berg, P. Veldhuis, Charles H.C.M. Buys, Susan L. Naylor	135
7	An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo. 1996 ·PubMed ·Maria C. Todd, (unknown), Dawn Garcia, (unknown), Shanna L. Moore, Charles H. Hensel, Paul Liu, Michael J. Siciliano, Klaas Kok, Anke van den Berg, P. Veldhuis, Charles H.C.M. Buys, Ann M. Killary, Susan L. Naylor	39
8	A homozygous deletion at FRA3B in a lung adenocarcinoma cell line with normal expression of the FHIT gene 1996 ·Cancer Genetics and Cytogenetics ·(unknown), Anke van den Berg, (unknown), Tineke Timmer, Anneke Y. van der Veen, P. Veldhuis, Susan L. Naylor, Jeremy C. Smith, Charles H.C.M. Buys	1
9	A homozygous deletion in a small cell lung cancer cell line involving a 3p21 region with a marked instability in yeast artificial chromosomes 1995 ·Lung Cancer ·Klaas Kok, Anke van den Berg, P. Veldhuis, (unknown), (unknown), (unknown), Miriam Hulsbeek, (unknown), (unknown), (unknown)	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact